Microbial Colonization
1
Pipeline Programs
7
Companies
6
Clinical Trials
0
Approved Products
Pipeline by Development Stage
Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
1
Early DiscoveryClinical DevelopmentMarket
Competitive Landscape
6 companies ranked by most advanced pipeline stage
Allergy TherapeuticsUK - West Sussex
1 programOneBiome microbiome profiling serviceN/A1 trial
Active Trials
Trial Timeline
Clinical trial activity over time
2021
2022
2023
2024
2025
2026
2027
Paratek PharmaceuticalsOmadacycline Injection
Human BioSciencesAmpicillin
Human BioSciencesAmpicillin
Allergy TherapeuticsOneBiome microbiome profiling service
Verona PharmaMicrobiome evaluation
Becton DickinsonCHG/IPA
Clinical Trials (6)
Total enrollment: 2,472 patients across 6 trials
Effects of Intravenous (IV) Omadacycline on Gut Microbiome
Start: Mar 2023Est. completion: Jul 20238 patients
Phase 4Completed
NICU Antibiotics and Outcomes Trial
Start: Aug 2020Est. completion: Jan 2026359 patients
Phase 4Completed
Optimizing PreTerm Infant Ampicillin Dosing
Start: Jul 2026Est. completion: Dec 202760 patients
Phase 1/2Not Yet Recruiting
MSC - OneBiome UX Pilot Study
Start: Sep 2021Est. completion: Apr 202290 patients
N/ACompleted
The Microbiome of Pancreatic Cancer: "PANDEMIC" Study
Start: Feb 2020Est. completion: Dec 202420 patients
N/AUnknown
Evaluation of the Antimicrobial Effectiveness of CHG/IPA
Start: Apr 2019Est. completion: Dec 20191,935 patients
N/ACompleted
Phase Legend
Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available
Key Insights
7 companies competing in this space
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.